Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

Overview of attention for article published in Vascular Health and Risk Management, May 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice

Article in PLOS ONE (May 2021)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus

Article in Diabetes Metabolic Syndrome and Obesity (June 2020)

Approaches to Clinical Development of Combination Medicines in the Russian Federation and the Eurasian Economic Union in view of the Requirements of the Current Legislation

Article in The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation (March 2019)

Dove Medical Press

Article Metrics